- Home
- UNCY vs VATE Comparison
UNCY vs VATE Comparison
Compare UNCY & VATE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- UNCY
- VATE
- Stock Information
- Founded
- UNCY 2016
- VATE 1994
- Country
- UNCY United States
- VATE United States
- Employees
- UNCY N/A
- VATE N/A
- Industry
- UNCY Biotechnology: Pharmaceutical Preparations
- VATE Metal Fabrications
- Sector
- UNCY Health Care
- VATE Industrials
- Exchange
- UNCY Nasdaq
- VATE Nasdaq
- Market Cap
- UNCY 70.3M
- VATE 63.4M
- IPO Year
- UNCY 2021
- VATE 1996
- Fundamental
- Price
- UNCY $0.62
- VATE $5.11
- Analyst Decision
- UNCY Strong Buy
- VATE
- Analyst Count
- UNCY 4
- VATE 0
- Target Price
- UNCY $5.50
- VATE N/A
- AVG Volume (30 Days)
- UNCY 1.3M
- VATE 59.8K
- Earning Date
- UNCY 11-13-2024
- VATE 03-03-2025
- Dividend Yield
- UNCY N/A
- VATE N/A
- EPS Growth
- UNCY N/A
- VATE N/A
- EPS
- UNCY N/A
- VATE N/A
- Revenue
- UNCY N/A
- VATE $1,231,500,000.00
- Revenue This Year
- UNCY N/A
- VATE N/A
- Revenue Next Year
- UNCY N/A
- VATE N/A
- P/E Ratio
- UNCY N/A
- VATE N/A
- Revenue Growth
- UNCY N/A
- VATE N/A
- 52 Week Low
- UNCY $0.20
- VATE $3.25
- 52 Week High
- UNCY $1.82
- VATE $10.80
- Technical
- Relative Strength Index (RSI)
- UNCY 40.04
- VATE 47.68
- Support Level
- UNCY $0.61
- VATE $4.72
- Resistance Level
- UNCY $0.73
- VATE $5.77
- Average True Range (ATR)
- UNCY 0.07
- VATE 0.37
- MACD
- UNCY -0.02
- VATE -0.04
- Stochastic Oscillator
- UNCY 15.66
- VATE 35.78
About UNCY Unicycive Therapeutics Inc.
Unicycive Therapeutics Inc is a biotechnology company dedicated to developing treatments for certain medical conditions. It is focusing on kidney diseases. The company's lead drug, Renazorb, is a novel phosphate-binding agent being developed for the treatment of hyperphosphatemia. Unicycive's other drug, UNI-494, is a new chemical entity with the issued composition of matter patent protection in late preclinical development for the treatment of acute kidney injury.
About VATE INNOVATE Corp.
Innovate Corp is a diversified holding company that has a portfolio of subsidiaries in a variety of operating segments which are; The infrastructure segment is comprised of DBM Global Inc, a fully integrated industrial construction, structural steel, and facility maintenance provider that provides fabrication and erection of structural steel and heavy steel plate services, The Life Sciences segment is comprised of Pansend Life Sciences which seeks to develop products to treat early osteoarthritis of the knee and aesthetic and medical technologies for the skin, and Spectrum segment is comprised of HC2 Broadcasting Holdings Inc which operates over-the-air broadcasting stations across the United States.